Dr. Mark Sonnenschine, DO

  • Brooklyn, NY
  • Hematologist and oncologist
NPI1922291939PAC ID1850443870
Medicare services, 2024
53,499
Medicare patients, 2024
420
Part D claims, 2024
1,212
Publications
1
Hospital affiliations
2
Practice address
4802 Tenth Avenue, Brooklyn, NY 11219
Practice phone
Call (718) 283-6000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Maimonides Medical Center

Hospital · Brooklyn, New York

See all 6 affiliations

Find Dr. Sonnenschine's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Mark Sonnenschine is a hematologist and oncologist in Brooklyn, New York

Dr. Sonnenschine practices at Maimonides Medical Center in Brooklyn, New York, part of Maimonides Medical Center.

Dr. Sonnenschine's NPI, 1922291939, was assigned on August 22, 2007. Dr. Sonnenschine graduated from New York College of Osteo Medicine of New York Institute of Technology in 2003. Dr. Sonnenschine holds New York license 242242.

NPI and contact details
Medicare PAC ID
1850443870
NPI enumeration date
August 22, 2007
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(718) 283-6000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
49
Medical school graduation
2003

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Mark Sonnenschine practices at Maimonides Medical Center in Brooklyn, New York

Dr. Sonnenschine's primary practice is Maimonides Medical Center, at 4802 Tenth Avenue, Brooklyn, NY 11219 in Kings County. The practice phone is (718) 283-6000.

Source: Dmand AI Affiliation Data

Dr. Mark Sonnenschine is affiliated with 4 sites of care and 2 medical groups

Dr. Sonnenschine's primary practice is Maimonides Medical Center in Brooklyn, New York, part of Maimonides Medical Center. Dr. Sonnenschine is also affiliated with NYC Health + Hospitals/South Brooklyn Health, Ruth Bader Ginsburg Hospital. The medical group on file is Physician Affiliate Group of New York (PAGNY). Dmand AI also links Dr. Sonnenschine to 1 more physician office, 1 home health agency and 1 medical group, each named with a free account.

See all 6 affiliations for Dr. Sonnenschine

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Mark Sonnenschine's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sonnenschine practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Maimonides Medical CenterAvailable with a free account
+3 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Sonnenschine practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Maimonides Medical Center and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Mark Sonnenschine is one of 996 hematologists and oncologists in New York

Hematology and oncology is Dr. Sonnenschine's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Sonnenschine is licensed in New York.

Specialties and state licenses

  • Hematology and oncology, New YorkPrimaryLicense 242242 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Sonnenschine

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Mark Sonnenschine billed Medicare for 53,499 services in 2024

CMS data shows 53,499 Medicare services from Dr. Sonnenschine across 10 procedure codes in 2024, for 420 Medicare patients. Medicare paid $177,257 for them.

Medicare services, 202453,499
Medicare patients420
Paid by Medicare$177,257
Procedure codes10

Dr. Sonnenschine's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 59,4612024: 51,71013%
Office and hospital visits
2023: 1,7652024: 1,35223%
Tests and treatments
2023: 2742024: 2595%
Surgery
2023: 2152024: 17817%

Where Dr. Sonnenschine's Medicare services took place, 2024

  • In an office52,52298%
  • In a facility9772%

Dr. Sonnenschine compared with the New York median for hematologists and oncologists, 2024

  • Dr. Sonnenschine
  • New York median
Medicare services
53,499vs 66880.1 times
Medicare patients
420vs 2102.0 times
Part D claims
610vs 2582.4 times

Medians across 940 hematologists and oncologists in New York with Dmand AI profiles that report each measure.

Dr. Sonnenschine's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Sonnenschine

Need commercial claims for Dr. Sonnenschine?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Sonnenschine and other hematologists and oncologists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Mark Sonnenschine treated 420 Medicare patients in 2024, average age 81

CMS counts 420 Medicare patients who saw Dr. Sonnenschine in 2024. The largest group is 85 and over, with 170 patients. 75% of them have diabetes, and 75% have high blood pressure. 68% are also on Medicaid. Their average risk score is 3.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sonnenschine's median patient age at 69, with 55% women.

Medicare patients, 2024420
Average age81
Average risk score3.19
Also on Medicaid68%

Dr. Sonnenschine's Medicare patients by age, 2024

Dr. Sonnenschine's Medicare patients by sex, 2024

  • Women22153%
  • Men19947%

Chronic conditions among Dr. Sonnenschine's Medicare patients, 2024

  1. Diabetes75%
  2. High blood pressure75%
  3. High cholesterol75%
  4. Arthritis70%
  5. Ischemic heart disease65%
  6. Heart failure61%
  7. Chronic kidney disease54%
  8. Atrial fibrillation44%

Share of Medicare patients with each condition. A patient can have several.

Dr. Sonnenschine's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 69

Patient panel by sex, all payers

  • Women55%
  • Men43%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Mark Sonnenschine wrote 1,212 Medicare Part D claims in 2024

In 2024, Dr. Sonnenschine wrote 1,212 Medicare Part D claims for 153 patients. 73% of them were for generic drugs. CMS names the drug for 610 of them, across 34 drugs with 11 or more claims each, at $522,565 in total drug cost. In 2023, CMS named 746 claims across 44 drugs.

Part D claims, 20241,212
Drugs named by CMS34
Total drug cost$522,565
Part D patients153

Dr. Sonnenschine's Part D claims by kind of drug, 2024

  • Generic882 claims73%
  • Brand-name and other330 claims27%

Dr. Sonnenschine's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Sonnenschine's Part D claims, 2024

  • Opioids9%107 of 1,212 claims
  • Antibiotics8%98 of 1,212 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 7462024: 61018%

Drugs named by CMS: 34 in 2024, 44 in 2023.

See all prescribing by Dr. Sonnenschine

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Mark Sonnenschine offers telehealth to Medicare patients

Dr. Sonnenschine accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sonnenschine as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Sources: Doctors and Clinicians National Downloadable File (CMS); and Doctors and Clinicians Utilization Data (CMS)

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Sonnenschine by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Mark Sonnenschine has 1 publication on record

Dmand AI links 1 paper to Dr. Sonnenschine in 2020. Dr. Sonnenschine's most frequent co-author is Abdul Basit, MD.

Papers1

Dr. Sonnenschine's most frequent co-authors

Recent publications by Dr. Sonnenschine

See all 1 publications and co-authors

See who Dr. Sonnenschine researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Sonnenschine works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Mark Sonnenschine received $17,400 in industry payments from 2016 to 2025

CMS Open Payments shows 714 general payments to Dr. Sonnenschine from 54 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 79% of the total. Novartis Pharmaceuticals Corporation paid the most, $3,892.

General payments to Dr. Sonnenschine by program year, 2016 to 2025

General payments to Dr. Sonnenschine by kind, 2016 to 2025

$17.4Kin total
  • Food and beverage$13,66979%
  • Device or supply loans$1,3658%
  • Education$1,2157%
  • Gifts$1,1527%

Companies that paid Dr. Sonnenschine the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Sonnenschine

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Mark Sonnenschine graduated from New York College of Osteo Medicine of New York Institute of Technology

Dr. Sonnenschine graduated from New York College of Osteo Medicine of New York Institute of Technology in 2003.

  1. Medical schoolNew York College of Osteo Medicine of New York Institute of Technology

Source: Dmand AI Professional Profile Data

Sources for Dr. Mark Sonnenschine's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Mark Sonnenschine

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Mark Sonnenschine's NPI number?

Dr. Mark Sonnenschine's NPI number is 1922291939. It was assigned on August 22, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Mark Sonnenschine?

Dr. Mark Sonnenschine is a hematologist and oncologist in Brooklyn, New York. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Mark Sonnenschine practice?

Dr. Sonnenschine practices at 4802 Tenth Avenue, Brooklyn, NY 11219. Dr. Sonnenschine's primary practice is Maimonides Medical Center in Brooklyn, New York, part of Maimonides Medical Center. Dmand AI also links Dr. Sonnenschine to 1 physician office, 1 home health agency and 1 medical group.

What is Dr. Mark Sonnenschine's office phone number?

The practice phone on file for Dr. Sonnenschine is (718) 283-6000.

What is Dr. Mark Sonnenschine's medical license number?

Dr. Sonnenschine holds New York license 242242.

Which hospitals is Dr. Mark Sonnenschine affiliated with?

Dr. Sonnenschine practices at Maimonides Medical Center in Brooklyn, New York. Dr. Sonnenschine is also affiliated with NYC Health + Hospitals/South Brooklyn Health, Ruth Bader Ginsburg Hospital.

What medical group is Dr. Mark Sonnenschine part of?

Dr. Sonnenschine is linked to Physician Affiliate Group of New York (PAGNY). Dmand AI links Dr. Sonnenschine to 1 more medical group.

Does Dr. Mark Sonnenschine accept Medicare?

Yes. CMS data shows Dr. Sonnenschine billed Medicare for 53,499 services in 2024, and Dr. Sonnenschine accepts Medicare assignment.

Does Dr. Mark Sonnenschine offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Sonnenschine as offering telehealth services.

How many Medicare patients does Dr. Mark Sonnenschine see?

CMS counts 420 Medicare patients who saw Dr. Sonnenschine in 2024, with an average age of 81.

Show 7 more questionsShow fewer questions

What services does Dr. Mark Sonnenschine bill to Medicare?

In 2024, Dr. Sonnenschine's most billed Medicare services were injected or infused drug (J1439), injected or infused drug (J0885) and hospital inpatient care (99232).

Where did Dr. Mark Sonnenschine go to medical school?

Dr. Sonnenschine graduated from New York College of Osteo Medicine of New York Institute of Technology in 2003.

What drugs does Dr. Mark Sonnenschine prescribe most?

In 2024 Medicare Part D data, Dr. Sonnenschine's most prescribed drugs by claims were Procrit, Mupirocin and Gabapentin.

Has Dr. Mark Sonnenschine received payments from drug or device companies?

CMS Open Payments shows $17,400 in general payments to Dr. Sonnenschine from 54 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.

How long has Dr. Mark Sonnenschine been practicing?

Dr. Sonnenschine graduated from medical school in 2003, 23 years ago.

Does Dr. Mark Sonnenschine do research?

Dmand AI links 1 publication to Dr. Sonnenschine.

Who does Dr. Mark Sonnenschine publish with?

Dr. Sonnenschine's most frequent co-authors are Abdul Basit, MD (1 shared paper).

Selling to hematology and oncology practices?

See hematologists and oncologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)